| Document |
Document Title |
|
WO/2024/059947A1 |
The present disclosure relates to molecular recognition elements (MREs) and, in particular, to aptamers for recognizing and binding to a microorganism, a virus, and/or a molecule present on a microorganism or virus, such as spike protein...
|
|
WO/2024/061513A1 |
Device (1) for measuring the gaseous contamination of a transport carrier (2) for conveying and storing at least one semiconductor substrate (6) at atmospheric pressure, said carrier (2) comprising a door (4b) and a shell (4a) that can b...
|
|
WO/2024/064390A1 |
Systems and methods here may be used for a setup of image capturing of a gemstone, such as a diamonds that are of high clarity grades. The present embodiments can provide methods to capture a diamond surface and internal clarity features...
|
|
WO/2024/061930A1 |
The present invention relates to treatment and diagnostic of peripheral t-cell lymphoma (PTCL). In this study, the inventors showed that cutaneous T-cell lymphoma (CTCL) lines and KIR3DL2+ SC are ICOS+ and ICOSL+. Normal T lymphocytes ar...
|
|
WO/2024/064789A1 |
Aspects are provided for a connected monitoring device for monitoring and reporting measurements. The monitoring device includes a plurality of sockets, each socket configured to receive a smart probe including a memory storing calibrati...
|
|
WO/2024/061273A1 |
The present invention relates to a compound represented by formula (I) and blocking agents capable of specifically binding to the compound represented by formula I, biotin, and a metabolite. The biotin blocking agents of the present inve...
|
|
WO/2024/063408A1 |
A water dispensing device, according to one embodiment of the present disclosure, comprises: a water supply channel through which raw water supplied from a water supply source flows; a filter which generates purified water by filtering t...
|
|
WO/2024/062993A1 |
Provided is a method for assisting in determining a treatment plan for a dog that has a skin condition like atopic dermatitis. Provided is a method that includes the following steps: a) a step for measuring the TARC level included in a...
|
|
WO/2024/061962A1 |
This invention provides a method for assessing the copper corrosion potential of a lubricant fluid comprising the steps of: a) placing a sample of said lubricant fluid in a vial, wherein said sample partially fills said vial, such that a...
|
|
WO/2024/062102A1 |
The present invention provides a method for detecting two target molecules in a sample, both as individual molecules and in proximity, or interaction with one another. The method involves performing three separate assay reactions to dete...
|
|
WO/2024/061128A1 |
Disclosed in the present invention is a use of a reagent for measuring the expression level of discoidin domain receptor 2 (DDR2) in the preparation of a kit for diagnosing neurodegenerative diseases of a subject. If the level of DDR2 in...
|
|
WO/2024/062406A1 |
The present invention relates to a method for forming functional materials, and particularly cross-linked active matrices, for regulating, limiting and blocking oxygen in in vitro cell culturing and packaging for food and beverages, onto...
|
|
WO/2024/061373A1 |
Provided in the present disclosure are a digital micro-fluidic apparatus, a driving method therefor, and the use thereof. The digital micro-fluidic apparatus comprises a digital micro-fluidic chip (10), the digital micro-fluidic chip (10...
|
|
WO/2024/061281A1 |
A kit for detecting prostate cancer and the use thereof, and a kit for detecting bladder cancer and the use thereof. The kit for detecting prostate cancer comprises sarcosine oxidase, metal nanoparticles, a gold nanomaterial, and a reage...
|
|
WO/2024/060616A1 |
The present invention provides a high-throughput detection method for target binding specificity of an antibody or a CAR-T cell, the specificity being for a membrane protein, in particular. The present invention also provides a method fo...
|
|
WO/2024/061725A1 |
The invention relates to a measuring station (1) for measuring airborne molecular contamination, comprising at least one gas analyser (3) and at least one sampling line (L1, Ln) fluidically connected to an inlet of the gas analyser (3). ...
|
|
WO/2023/043892A9 |
The present invention generally pertains to methods of preventing disulfide scrambling in non-reducing liquid chromatography-mass spectrometry analysis of a protein of interest. In particular, the present invention pertains to the additi...
|
|
WO/2024/063526A1 |
The present invention relates to a method for prevention or treatment of fibrotic disease, wherein an antibody binding specifically to asporin protein involved in fibrosis is used for predicting the onset of fibrotic disease or for inhib...
|
|
WO/2024/063999A1 |
Disclosed herein are methods of generating intestinal organoids (IO) with immune cells (iIO) and methods of making an iIO with activated immune cells. IO compositions including immune cells, optionally including activated immune cells, (...
|
|
WO/2024/060854A1 |
A control method for a clothing care device, and the clothing care device. The control method for the clothing care device comprises the following steps: acquiring an image of clothing waiting for care (S1); preprocessing the image of sa...
|
|
WO/2024/063671A1 |
The invention relates to the field of medicine and is intended for performing real-time microscopic examinations of cervical and endocervical smears. A system for performing rapid cytological analysis of cervical disease within the time ...
|
|
WO/2024/062112A1 |
The present invention relates to a method of quantifying methane removal in the atmosphere. Specifically, the present invention relates to quantifying methane removal by iron-salt aerosols. The present invention also relates to the metho...
|
|
WO/2024/061920A1 |
The present invention refers to the use of specific metabolites for assessing the activity of NNMT, for selecting patients which may benefit from a treatment with NNMT inhibitors, for the prognosis and/or predicting the response of patie...
|
|
WO/2024/061223A1 |
Provided are an antibody and use thereof in resisting a tumor. Provided are a single-domain antibody capable of specifically binding to 4-1BB or an antigen-binding fragment thereof, and a multi-specific antibody. The antibody has improve...
|
|
WO/2024/064100A1 |
The system and method to measure, identify, and reduce food defects from manual or automated processes uses a combination of sensors, computer vision, and machine learning to optimize yield, and quality for food processes. Specific featu...
|
|
WO/2024/062101A1 |
The invention relates to a bi-specific agent, comprising an anchor region capable of binding a plasma cell, and a binding region associated with the anchor region, wherein the binding region comprises an epitope of an interferon, an inte...
|
|
WO/2024/062867A1 |
A method for analyzing the possibility of cancer developing in a subject according to an embodiment of the present invention comprises: counting, through comparison with a reference sequence, the number of types of RNA in which sequence ...
|
|
WO/2024/060326A1 |
Provided is an antibody combination for detecting the prognosis of nasopharyngeal cancer. The antibody combination comprises at least one of IGHM, IGHD, IGHA1, IGHA2, IGHG1, IGHG2, IGHG3, and IGHG4. Provided are use of the antibody combi...
|
|
WO/2024/064892A1 |
Embodiments herein describe systems and methods to generate a risk score for an individual to develop postoperative neurocognitive disorder (POND). Various embodiments obtain multi-omics data from an individual, such as genomics, transcr...
|
|
WO/2024/063234A1 |
The present invention relates to a method and an apparatus for measuring the degree of depolymerization of a polymer, capable of easily predicting the physical properties of the polymer. The method for measuring the degree of polymer dep...
|
|
WO/2024/061306A1 |
The present application discloses antibodies and antibody derivatives that bind to B7H3 (also known as CD276) and methods of using the same. The antibodies or antibody derivatives comprise a single domain antibody that binds to B7H3.
|
|
WO/2024/062130A1 |
The invention provides a system and method of estimating the amount of carbon dioxide stored in a storage formation. The method comprises associating at least one carbon dioxide source with at least one tracer and injecting the carbon di...
|
|
WO/2024/063636A1 |
The present invention provides a method for monitoring odours released from a soybean oil refinery plant, wherein the method comprises detecting, analysing, identifying and classifying a plurality of data by at least one sensing means us...
|
|
WO/2024/064160A1 |
Microphysiological platforms are configured for measuring kinetic rates relating to drug absorption. These kinetic rates include GI region-specific kinetic rates of drug absorption. The kinetic rates include bioavailability of the drug o...
|
|
WO/2024/064322A2 |
The present disclosure includes biomarkers, methods, devices, reagents, systems, and kits for predicting an individual's tobacco use status. In one aspect, the disclosure provides biomarkers that can be used alone or in various combinati...
|
|
WO/2024/059832A1 |
Provided are nucleic acids encoding kinase-modulated bioluminescent indicator (KiMBI) polypeptides. In certain embodiments, a nuclei acid of the present disclosure encodes a KiMBI polypeptide comprising a first bioluminescent enzyme frag...
|
|
WO/2024/059020A1 |
Embodiments presented provide for a method of monitoring emissions. A calibration of a metal oxide sensor is accomplished in order to monitor fugitive methane gas emissions on a consistent and constant basis.
|
|
WO/2024/059886A2 |
A photochemical sensor for measuring a selected gas in a fluid is provided. The sensor comprises a pump, scrubber and an absorption chamber. The pump is configured to pump the fluid in a first direction or a second direction. The scrubbe...
|
|
WO/2024/059773A2 |
Provided herein is a highly sensitive analyte detection method that involves catch and release of a target analyte coupled with a proximity assay.
|
|
WO/2024/057956A1 |
A method for collecting data for diagnosing cancer, determining the onset risk, determining the malignancy and/or predicting the prognosis of cancer according to the present disclosure comprises the steps of: (a) causing an antigen-antib...
|
|
WO/2024/059489A1 |
Methods, sample vessels, and instruments are provided for determining susceptibility of a bacterium to one or more classes of antibiotics.
|
|
WO/2024/057215A1 |
The device (1) comprises: - a tubular body (2) within which a working gas is conveyed, which extends along a relevant longitudinal axis (A) and defines a channel (3) for the passage of the working gas; - at least one detection cell (5) a...
|
|
WO/2024/059302A1 |
The present disclosure relates to systems and methods for screening a formulation of a material being printed in an additive manufacturing process, in situ, to enable rapid analysis, modeling and modification of at least one characterist...
|
|
WO/2024/058528A1 |
The present invention relates to a nanostructure containing polymersomes and quantum dots, and a virus detection method using the nanostructure, which has been confirmed to have high sensitivity and high specificity compared to conventio...
|
|
WO/2024/059655A1 |
A method including contacting an array of macromolecules with a plurality of different assay reagents, wherein individual addresses of the array are attached to single macromolecules, and the macromolecule comprising a plurality of diffe...
|
|
WO/2024/058781A1 |
An example device includes a substrate, a microfluidic network supported by the substrate, a magnet integrated with the substrate within a region of the microfluidic channel downstream from the sample fluid channel and the reporter fluid...
|
|
WO/2024/056168A1 |
A method of predicting a characteristic of an uncoated pharmaceutical product (101) during a manufacturing process, the method comprising (i) performing the manufacturing process of the uncoated pharmaceutical product (101); and (ii) mon...
|
|
WO/2024/058192A1 |
Provided is a novel antibody which may be used for the treatment of SARS-CoV-2. An antibody or an antigen-binding fragment thereof according to the present disclosure is an anti-CADM1 antibody or an antigen-binding fragment thereof, wh...
|
|
WO/2024/058178A1 |
The present invention provides a reagent that is for measuring an epidermal growth factor receptor tyrosine kinase activity and that contains: a modified polypeptide to which an acceptor and a donor inducing Förster resonance energy tra...
|
|
WO/2024/055075A1 |
The present invention relates to radiolabelled molecules, and related precursor molecules, for use in detecting immune cells expressing a receptor comprising an antigen binding site for binding to dysfunctional P2X7 receptor and a signal...
|
